The authors, Drs Marisa Adelman and Ingrid Nygaard, from the University of Utah School of Medicine, said: “The widespread clinical use of vaginal laser therapy, followed by burgeoning reports of adverse events and FDA [US Food and Drug Administration] warnings, brought an unfortunate sense of deja vu.
